Outcomes

Neurological manifestation of SARS-CoV-2: Inflammation and therapeutics This article discusses extrapulmonary infections and manifestations related to COVID-19. As discussed in previous articles, the usual complaints of ageusia, anosmia, myalgia, and headache are prominent in individuals, however, reports of stroke, encephalopathy, Read More
Trends in ER visits during the COVID-19 pandemic related to mental health and violence In this Journal of the American Medical Association Psychiatry publication, the authors discuss a cross-sectional study of nearly 190 million emergency department visits and found that Read More
COVID-19 Vaccines & Distribution Strategies As the nation prepare for the Phase 1a of the COVID-19 vaccine distribution plan, there is much conversation regarding who, when, and how this will be accomplished. In this early release article, the CDC states Read More
Multisystem Imaging Manifestations of COVID-19 In this article, authors discuss the effects of COVID-19 on multiple extrapulmonary systems. Widespread involvement of multiple body systems is attributed to the expression of ACE2 receptors in extrapulmonary tissues, resulting in direct tissue damage. Read More
This randomized, open-label trial found no significant difference in defined clinical outcomes between a 5 day vs 10 day course of remdesivir.  Inclusion criteria: >11 years of age, confirmed SARS-CoV-2 infection, oxygen saturation of 94% or less while they were Read More
THE ARTICLE DISCUSSED HAS BEEN RETRACTED. CLICK HERE TO SEE THE RETRACTION NOTICE. A multinational registry analysis found no evidence of benefit of hydroxychloroquine or chloroquine when used either alone or with a macrolide.  Using an international, observational registry across Read More
This retrospective cohort study found that 76.9% of the patients who were hospitalized with Covid-19 and 70.6% of those who died were black, whereas blacks comprise only 31% of the Ochsner Health population (in Louisiana.)  Study occurred within a integrated-delivery Read More
This case series described two patients who were infected with SARS-CoV-2 who had thrombotic strokes during ongoing anti-coagulation treatment for atrial fibrillation stroke prophylaxis.  Both cases involved men, ages 74 and 84 years old, each with multiple cardiovascular diseases, including Read More
This study found that admission C-reactive protein (CRP) correlated with disease severity and tended to be a good predictor of adverse outcome. Data of COVID-19 patients with clinical outcome in a designated hospital in Wuhan, China, were retrospectively collected and Read More
This prospective observational cohort study presents information on the epidemiology, clinical course, and outcomes of critically ill patients with COVID-19 in New York City. The study took place at two New York-Presbyterian hospitals affiliated with Columbia University Irving Medical Center Read More

Get Involved with Indiana CTSI